One degree, many destinations
BLS lists a Doctor of Pharmacy from an accredited program as the typical route into the profession. After licensure, graduates are concentrated in a few settings. Of the 325,200 pharmacist jobs BLS counted in 2025, 37% were in pharmacies and drug retailers, 32% in hospitals, and 6% each in general merchandise retailers, food and beverage retailers, and ambulatory healthcare services. The remaining 13% is spread across settings the page does not list individually (BLS Occupational Outlook Handbook).
The residency fork
BLS does not treat residency as required; it says pharmacists seeking a clinical or other advanced position may opt to complete a residency or fellowship. In the 2026 ASHP Resident Matching Program, 4,486 PGY1 applicants participated and 3,787 matched, an applicant match rate of 84%, for 4,221 PGY1 positions in the Match. A PGY2 adds a specialty; ASHP's 2026 summary lists PGY2 programs in ambulatory care, cardiology, critical care, emergency medicine, geriatrics and psychiatry, among others. Most PGY1 applicants (4,182 of 4,486) were 2026 graduates, so the decision falls in your final year. See ASHP's Match statistics.
Start with the right pharmacy school.
Pharmacy admissions no longer use the PCAT, so GPA carries most of the academic case. AdmitBase compares your GPA with published entering-class figures where schools publish them.
Get Started Free →Community and hospital practice
Pharmacies and drug retailers are the largest single employer of pharmacists by BLS's count, and hospitals are second. Each school publishes its own residency match and licensure results, so compare them on its outcomes page rather than relying on reputation. The AdmitBase pages for the UNC Eshelman School of Pharmacy and the UCSF School of Pharmacy show the admissions and tuition data AdmitBase holds for them.
Industry, managed care, and academia
BLS's five largest industries are pharmacies, hospitals, general merchandise, food and beverage retailers and ambulatory care, so drug development, managed care, academia and regulatory work have no line of their own, and the page gives no pay or count for them. AdmitBase has no hiring data for them either. If one of these is your goal, read current postings for the entry route employers actually use, which for some roles is a fellowship.
Match the path to the debt
AACP reports average student loan debt at graduation of around $171,000 across schools of pharmacy (2024 Graduating Student Survey), which is about 1.2 times BLS's $140,910 median wage; an average, not your case. In AdmitBase's verified rows, median first-year resident tuition is $32,000, with the 10th to 90th percentile running from about $15,600 to about $54,500, so the school you pick moves the debt more than the career you choose. BLS projects 5% employment growth for pharmacists from 2025 to 2035, about 17,100 jobs. See pharmacy school cost, debt, and ROI.
Checked 2026-11-17 against the BLS Occupational Outlook Handbook for pharmacists (May 2025 wage, 2025 employment by industry, 2025-35 projection), ASHP's 2026 Match summary reports, AACP's debt figure as cited on our PharmD vs. PhD page, and AdmitBase's verified tuition rows. Not checked: pay by setting, hiring for industry and managed-care roles, how many employers expect a residency.



